Suppr超能文献

评价中华稻蝗来源的新型 Xa 因子抑制剂的抗血小板聚集活性。

Evaluation of novel factor Xa inhibitors from Oxya chinensis sinuosa with anti-platelet aggregation activity.

机构信息

College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, BK21 Plus KNU Multi-Omics based Creative Drug Research Team, Kyungpook National University, Daegu, 41566, Republic of Korea.

College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.

出版信息

Sci Rep. 2017 Aug 11;7(1):7934. doi: 10.1038/s41598-017-08330-1.

Abstract

The edible grasshopper Oxya chinensis sinuosa is consumed worldwide for its various medicinal effects. The purpose of this study was to investigate potential bioactive antithrombotic and antiplatelet compounds from O. chinensis sinuosa. Five N-acetyldopamine dimers (1-5) were isolated from O. chinensis sinuosa and compounds 1 and 2 were identified as new chemicals with chiral centers at H-2 and H-3 of the benzo-1,4-dioxane structure. Compounds 1-4 were found to have both FXa and platelet aggregation inhibitory activities. These compounds inhibited the catalytic activity of FXa toward its synthetic substrate, S-2222, by noncompetitive inhibition, and inhibited platelet aggregation induced by ADP and U46619. Furthermore, compounds 1-4 showed enhanced antithrombotic effects, which were assessed using in vivo models of pulmonary embolism and arterial thrombosis. The isolated compounds also showed anticoagulant effects in mice. However, compounds 1-4 did not prolong bleeding time in mice, as shown by tail clipping. N-Acetyldopamine dimers, including two new stereoisomers 1 and 2, are novel antithrombotic compounds showing both FXa inhibition and antiplatelet aggregation activity with a low bleeding risk. Collectively, these results suggest that compounds 1-4 could serve as candidates and provide scaffolds for development of new antithrombotic drugs.

摘要

可食用的东亚飞蝗 Oxya chinensis sinuosa 因其多种药用功效而在全球范围内被食用。本研究旨在从东亚飞蝗中寻找具有潜在生物活性的抗血栓和抗血小板化合物。从东亚飞蝗中分离得到 5 个 N-乙酰多巴胺二聚体(1-5),其中化合物 1 和 2 被鉴定为具有手性中心的新型化合物,苯并-1,4-二恶烷结构的 H-2 和 H-3 上具有手性中心。化合物 1-4 均具有 FXa 和血小板聚集抑制活性。这些化合物通过非竞争性抑制抑制 FXa 对其合成底物 S-2222 的催化活性,并抑制 ADP 和 U46619 诱导的血小板聚集。此外,化合物 1-4 显示出增强的抗血栓作用,这通过肺栓塞和动脉血栓形成的体内模型进行评估。分离得到的化合物在小鼠体内也显示出抗凝作用。然而,化合物 1-4 通过剪断尾巴并未延长小鼠的出血时间。包括两个新立体异构体 1 和 2 在内的 N-乙酰多巴胺二聚体是新型抗血栓化合物,具有 FXa 抑制和抗血小板聚集活性,出血风险低。综上所述,这些结果表明,化合物 1-4 可作为候选物,为开发新型抗血栓药物提供了支架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c402/5554137/61684dda3f52/41598_2017_8330_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验